Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesCosmos Health Inc.

Cosmos Health Inc.

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
0.2088 USD -0.06 ( 22.03%)
Last update at 2026-11-10T15:07:00Z
VOLUME
2079037
Market Cap
27.94M

Momentum Score

…

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.20
Low
0.26
High
52 Week Price Range
0.16
Low
1.32
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Cosmos Health Inc. (NASDAQ: COSM) is limited and filings provide few details about its operations or product lines. The company appears positioned in the healthcare sector and may benefit if management can articulate scalable revenue streams and demonstrate execution on clinical, reimbursement or distribution initiatives that support long-term growth.
Key investment risks include limited disclosure and transparency, an unclear business model and revenue visibility, potential lack of operating history or profitability, and liquidity or financing uncertainty that could constrain execution.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.27
Dividend Yield
-
Revenue TTM
73.73M
Revenue Per Share
1.70
Gross Profit TTM
7.57M
Debt / Equity
0.59
ROE
-104.00%
Net Debt
10.08M
ROCE
-60.80%
Diluted EPS TTM
-0.67

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -19.14M -16.18M -18.54M -13.06M -7.85M
Net income -19.14M -16.18M -18.54M -13.83M -7.96M
Selling general administrative 15.62M 11.73M 25.40M 12.61M 11.68M
Selling and marketing expenses 0.15M 0.35M - 0.63M 0.73M
Gross profit 7.90M 4.31M 4.35M 5.96M 8.33M
Reconciled depreciation 1.37M 1.25M 0.61M 0.19M 0.45M
Ebit -16.54M -15.17M - -7.47M -4.53M
Ebitda -15.17M -13.92M - -9.47M -4.13M
Depreciation and amortization 1.37M 1.25M - -2.00M 0.41M
Operating income -16.70M -15.54M -21.83M -7.47M -4.53M
Other operating expenses 81.98M 69.97M - 57.82M 60.77M
Interest expense 2.62M 1.01M 0.87M 3.97M 3.58M
Tax provision 0.00M 0.00M 0.00M 0.78M 0.11M
Interest income 0.40M 0.41M 0.66M 0.24M 0.05M
Net interest income -2.23M -0.61M -0.20M -3.73M -3.53M
Income tax expense - 6.20M - 0.78M 0.11M
Total revenue 65.27M 54.43M 53.38M 50.35M 56.24M
Total operating expenses 24.60M 19.86M 75.21M 13.43M 12.86M
Cost of revenue 57.38M 50.12M 49.03M 44.39M 47.91M
Total other income expense net -2.44M -0.64M 3.49M -5.58M -3.31M
Net income from continuing ops -19.14M -16.18M -18.54M -13.83M -7.96M
Net income applicable to common shares - - - - -15.59M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 65.48M 54.31M 66.01M 68.04M 49.43M
Intangible assets 7.52M 7.71M 7.63M 0.66M 0.44M
Other current assets 12.22M 4.89M 6.25M 5.43M 1.05M
Total liab 47.05M 29.78M 29.97M 28.38M 45.05M
Total stockholder equity 18.42M 24.53M 36.04M 39.66M 4.38M
Other current liab 18.85M 4.84M 3.47M 1.52M 1.30M
Common stock 0.04M 0.02M - 0.01M 0.02M
Capital stock 0.04M 0.02M 0.02M 0.38M 0.02M
Retained earnings -133.17M -114.02M -91.64M -66.23M -34.35M
Good will 0.05M 0.05M 0.05M 0.05M 0.05M
Other assets - -0.00M - - 6.01M
Cash 0.72M 0.32M 3.83M 20.75M 0.29M
Total current liabilities 38.27M 25.76M 24.32M 21.75M 29.93M
Current deferred revenue - - - - 2.94M
Net debt 10.08M 11.51M 7.43M -8.72M 26.84M
Short term debt 4.79M 9.76M - 8.31M 13.56M
Short long term debt 13.52M 9.55M 8.23M 8.04M 13.34M
Short long term debt total 10.79M 11.82M - 12.03M 27.12M
Other stockholder equity 151.22M 140.67M - 106.64M 38.86M
Property plant equipment - - - - 1.88M
Total current assets 38.39M 25.46M 36.61M 56.04M 40.88M
Net tangible assets - - - - 3.89M
Short term investments 0.05M 0.02M 0.02M 0.01M 0.01M
Net receivables 19.63M 15.88M 19.76M 26.40M 30.14M
Long term debt 5.85M 1.56M 3.04M 2.86M 12.72M
Inventory 5.78M 4.36M 4.79M 3.45M 3.15M
Accounts payable 14.62M 11.16M 11.91M 11.92M 12.13M
Accumulated other comprehensive income 0.33M -2.13M - -1.13M -0.15M
Non currrent assets other 8.34M 4.92M 1.06M 8.36M 0.92M
Non current assets total 27.09M 28.85M 29.41M 11.99M 8.55M
Capital lease obligations 0.60M 0.71M 1.16M 1.12M 1.06M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.80M 0.00M -0.02M -0.83M
Change to liabilities - - - - 3.82M
Total cashflows from investing activities -2.01M -0.80M - - -0.83M
Net borrowings 10.47M 0.55M -0.02M - 7.39M
Total cash from financing activities 14.06M 5.05M 12.69M 35.05M 7.27M
Change to operating activities - - - - -4.86M
Net income -19.14M -16.18M -25.78M -13.83M -7.96M
Change in cash 3.14M -3.52M -16.92M 20.46M -0.34M
Begin period cash flow 0.32M 3.83M 20.75M 0.29M 0.63M
End period cash flow 3.46M 0.32M 3.83M 20.75M 0.29M
Total cash from operating activities -8.45M -7.72M -15.64M -14.87M -7.10M
Issuance of capital stock 5.42M 0.65M 10.00M 41.28M 0.25M
Depreciation 1.37M 1.25M 0.61M 0.19M 0.45M
Other cashflows from investing activities -1.96M -0.38M - - 0.06M
Dividends paid - 6.20M - -32.00M -7.63M
Change to inventory -0.83M 0.15M -0.89M -0.49M -0.09M
Change to account receivables -6.11M 1.23M -4.03M -3.24M -5.79M
Sale purchase of stock - -0.10M -0.10M 0.00M -0.38M
Other cashflows from financing activities -1.83M 10.04M - 72.17M 40.69M
Change to netincome - - - - 5.96M
Capital expenditures 0.06M 0.42M 9.17M 0.38M 0.89M
Change in working capital -0.78M 0.16M -7.90M -8.69M -6.30M
Stock based compensation 2.31M 1.69M 0.58M 0.02M 5.90M
Other non cash items 7.77M 5.38M -0.98M 6.66M 1.52M
Free cash flow -8.50M -8.14M -24.80M -15.25M -7.99M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COSM
Cosmos Health Inc.		 -0.06
22.03%		 0.21 - 3.87 0.38 1.32 0.56 -1.60
MCK
McKesson Corporation		 4.53
0.43%		 1063.90 24.45 20.41 0.26 5.04 0.27 15.03
COR
Cencora Inc.		 -2.51
0.73%		 343.25 24.22 16.39 0.19 20.41 0.21 13.72
CAH
Cardinal Health Inc		 -0.93
0.34%		 273.36 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 0.05
0.06%		 88.46 25.89 15.08 0.72 3.14 1.00 13.43

Profile*

Cosmos Health Inc.

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece, 55438

312 536 3102

https://www.cosmoshealthinc.com

163

Name Title Year Born
Mr. Grigorios Siokas Chairman & CEO 1965
Mr. Georgios Terzis Chief Financial Officer 1982
Mr. Pavlos Ignatiades Chief Operating Officer 1963
Mr. Demetrios G. Demetriades Sec. & Independent Director 1966
Mr. Demetrios G. Demetriades Secretary & Independent Director 1966
Mr. Nikolaos Bardakis Chief Operating Officer 1969
Mr. Georgios Terzis Chief Financial Officer 1983
Mr. Demetrios G. Demetriades Secretary & Independent Director 1965
Prof. Dimitrios Trafalis Head of Oncology NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…